Skip to main content
Nykode Therapeutics AS (OSL:NYKD)
Norway flag Norway · Delayed Price · Currency is NOK
3.050
-0.030 (-0.97%)
Apr 29, 2026, 4:25 PM CET

Nykode Therapeutics AS Revenue

In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K USD, down -95.05%.

Revenue
$453.00K
Revenue Growth
-95.05%
P/S Ratio
220.25
Revenue / Employee
$7.68K
Employees
59
Market Cap
1.01B NOK

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025453.00K-8.71M-95.05%
Dec 31, 20249.16M-4.17M-31.26%
Dec 31, 202313.32M4.29M47.56%
Dec 31, 20229.03M-26.74M-74.76%
Dec 31, 202135.77M-179.93M-83.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ArcticZymes Technologies ASA 118.21M
Lytix Biopharma ASA 377.00K
Zelluna ASA 53.00K
Thor Medical ASA 839.00K
Circio Holding ASA 123.00K
SoftOx Solutions AS 15.58M
Oncoinvent ASA 28.07M
EXACT Therapeutics AS 59.00K
Revenue Rankings

Nykode Therapeutics AS News

More News